The global cGMP Process Development market was valued at US$ 4108 million in 2025 and is anticipated to reach US$ 6437 million by 2032, at a CAGR of 6.7% from 2026 to 2032.

cGMP Process Development Market

cGMP process development refers to a series of development activities that systematically design, optimize, scale up, and validate a pharmaceutical manufacturing process under a quality system that complies with current Good Manufacturing Practices (GMP) requirements. The goal is to establish a manufacturable, repeatable, scalable, transferable, and long-term compliant manufacturing process.

Gross Margin Levels

The gross margin for cGMP process development exhibits a clear stratification based on "capability complexity + compliance costs + resource utilization": For highly standardized small molecule process exploration and routine analytical method development, competition is more intense, and gross margins typically fall between 25% and 35%. Integrated CDMOs with platform capabilities and seamless integration with clinical/commercial manufacturing, due to stronger customer loyalty and the ability to deliver packages (development + technology transfer + clinical approval), gross margins are more commonly between 30% and 45%. In high-barrier-to-entry areas such as ADCs, cell and gene therapy, viral vectors, and sterile preparations, constrained by highly skilled personnel, compliance documentation systems, and limited capacity, gross margins can reach 40%–55% if capacity utilization is good. Publicly available comparable metrics show that the industry's commonly disclosed EBITDA margin for CDMO businesses is mostly around 20%–30%+, which also reflects the strong profitability elasticity of this type of service driven by scale and high-value-added projects.

Industry Drivers

The growth of cGMP process development is driven by three converging forces: First, pharmaceutical companies and biotech firms, under pressure to improve financial efficiency and R&D returns, are continuously outsourcing CMC and manufacturing-related work. Many believe that outsourcing growth is likely to outpace overall pharmaceutical growth in the medium term, accelerating the adoption of end-to-end outsourcing models from process development to technology transfer to clinical/commercial manufacturing. Second, the increasing proportion of biologics and novel therapies (such as macromolecules and advanced therapies) is upgrading process development from simply "being able to manufacture" to "scalable, verifiable, and sustainably compliant," placing higher demands on process characterization, QbD, contamination control, and aseptic assurance, thereby increasing the value of individual projects and reliance on outsourcing. Third, changes in the global supply chain and regulatory environment are driving the industry towards a more controllable compliance system and regionalized capacity layout. Leading CDMOs are continuously restructuring and investing around high-value platforms and capacities, further accelerating clients' commitment to binding key process development stages to service providers with global compliance and scalable delivery capabilities.

This report delivers a comprehensive overview of the global cGMP Process Development market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding cGMP Process Development. The cGMP Process Development market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global cGMP Process Development market comprehensively. Regional market sizes by Type, by Application, by Service Phase, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist cGMP Process Development manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of cGMP Process Development Market Report

Report Metric	Details
Report Name	cGMP Process Development Market
Accounted market size in 2025	US$ 4108 million
Forecasted market size in 2032	US$ 6437 million
CAGR	6.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Microbial cGMP Manufacturing Mammalian cGMP Manufacturing Others
Segment by Service Phase	Preclinical Process Development Clinical-Stage Process Development Commercialization Process Development
Segment by Technology Platform	Chemical Synthesis Process Development Platform Cell Culture Process Development Platform Others
Segment by Application	Pharmaceutical Biotechnology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza, Thermo Fisher Scientific, Catalent, Samsung Biologics, WuXi Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, Recipharm, Siegfried, Cambrex, WuXi STA, Piramal Pharma Solutions, Evonik Health Care, AGC Biologics, Rentschler Biopharma, KBI Biopharma, Curia, Almac Pharma Services
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Service Phase, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for cGMP Process Development companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is cGMP Process Development Market growing?

Ans: The cGMP Process Development Market witnessing a CAGR of 6.7% during the forecast period 2026-2032.

What is the cGMP Process Development Market size in 2032?

Ans: The cGMP Process Development Market size in 2032 will be US$ 6437 million.

Who are the main players in the cGMP Process Development Market report?

Ans: The main players in the cGMP Process Development Market are Lonza, Thermo Fisher Scientific, Catalent, Samsung Biologics, WuXi Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, Recipharm, Siegfried, Cambrex, WuXi STA, Piramal Pharma Solutions, Evonik Health Care, AGC Biologics, Rentschler Biopharma, KBI Biopharma, Curia, Almac Pharma Services

What are the Application segmentation covered in the cGMP Process Development Market report?

Ans: The Applications covered in the cGMP Process Development Market report are Pharmaceutical, Biotechnology, Others

What are the Type segmentation covered in the cGMP Process Development Market report?

Ans: The Types covered in the cGMP Process Development Market report are Microbial cGMP Manufacturing, Mammalian cGMP Manufacturing, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global cGMP Process Development Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Microbial cGMP Manufacturing

1.2.3 Mammalian cGMP Manufacturing

1.2.4 Others

1.3 Market by Service Phase

1.3.1 Global cGMP Process Development Market Size Growth Rate by Service Phase: 2021 vs 2025 vs 2032

1.3.2 Preclinical Process Development

1.3.3 Clinical-Stage Process Development

1.3.4 Commercialization Process Development

1.4 Market by Technology Platform

1.4.1 Global cGMP Process Development Market Size Growth Rate by Technology Platform: 2021 vs 2025 vs 2032

1.4.2 Chemical Synthesis Process Development Platform

1.4.3 Cell Culture Process Development Platform

1.4.4 Others

1.5 Market by Application

1.5.1 Global cGMP Process Development Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Pharmaceutical

1.5.3 Biotechnology

1.5.4 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global cGMP Process Development Market Perspective (2021–2032)

2.2 Global cGMP Process Development Growth Trends by Region

2.2.1 Global cGMP Process Development Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 cGMP Process Development Historic Market Size by Region (2021–2026)

2.2.3 cGMP Process Development Forecasted Market Size by Region (2027–2032)

2.3 cGMP Process Development Market Dynamics

2.3.1 cGMP Process Development Industry Trends

2.3.2 cGMP Process Development Market Drivers

2.3.3 cGMP Process Development Market Challenges

2.3.4 cGMP Process Development Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top cGMP Process Development Players by Revenue

3.1.1 Global Top cGMP Process Development Players by Revenue (2021–2026)

3.1.2 Global cGMP Process Development Revenue Market Share by Players (2021–2026)

3.2 Global Top cGMP Process Development Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by cGMP Process Development Revenue

3.4 Global cGMP Process Development Market Concentration Ratio

3.4.1 Global cGMP Process Development Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by cGMP Process Development Revenue in 2025

3.5 Global Key Players of cGMP Process Development Head Offices and Areas Served

3.6 Global Key Players of cGMP Process Development, Products and Applications

3.7 Global Key Players of cGMP Process Development, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 cGMP Process Development Breakdown Data by Type

4.1 Global cGMP Process Development Historic Market Size by Type (2021–2026)

4.2 Global cGMP Process Development Forecasted Market Size by Type (2027–2032)

5 cGMP Process Development Breakdown Data by Application

5.1 Global cGMP Process Development Historic Market Size by Application (2021–2026)

5.2 Global cGMP Process Development Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America cGMP Process Development Market Size (2021–2032)

6.2 North America cGMP Process Development Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America cGMP Process Development Market Size by Country (2021–2026)

6.4 North America cGMP Process Development Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe cGMP Process Development Market Size (2021–2032)

7.2 Europe cGMP Process Development Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe cGMP Process Development Market Size by Country (2021–2026)

7.4 Europe cGMP Process Development Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific cGMP Process Development Market Size (2021–2032)

8.2 Asia-Pacific cGMP Process Development Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific cGMP Process Development Market Size by Region (2021–2026)

8.4 Asia-Pacific cGMP Process Development Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America cGMP Process Development Market Size (2021–2032)

9.2 Latin America cGMP Process Development Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America cGMP Process Development Market Size by Country (2021–2026)

9.4 Latin America cGMP Process Development Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa cGMP Process Development Market Size (2021–2032)

10.2 Middle East & Africa cGMP Process Development Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa cGMP Process Development Market Size by Country (2021–2026)

10.4 Middle East & Africa cGMP Process Development Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lonza

11.1.1 Lonza Company Details

11.1.2 Lonza Business Overview

11.1.3 Lonza cGMP Process Development Introduction

11.1.4 Lonza Revenue in cGMP Process Development Business (2021–2026)

11.1.5 Lonza Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific cGMP Process Development Introduction

11.2.4 Thermo Fisher Scientific Revenue in cGMP Process Development Business (2021–2026)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Catalent

11.3.1 Catalent Company Details

11.3.2 Catalent Business Overview

11.3.3 Catalent cGMP Process Development Introduction

11.3.4 Catalent Revenue in cGMP Process Development Business (2021–2026)

11.3.5 Catalent Recent Development

11.4 Samsung Biologics

11.4.1 Samsung Biologics Company Details

11.4.2 Samsung Biologics Business Overview

11.4.3 Samsung Biologics cGMP Process Development Introduction

11.4.4 Samsung Biologics Revenue in cGMP Process Development Business (2021–2026)

11.4.5 Samsung Biologics Recent Development

11.5 WuXi Biologics

11.5.1 WuXi Biologics Company Details

11.5.2 WuXi Biologics Business Overview

11.5.3 WuXi Biologics cGMP Process Development Introduction

11.5.4 WuXi Biologics Revenue in cGMP Process Development Business (2021–2026)

11.5.5 WuXi Biologics Recent Development

11.6 FUJIFILM Diosynth Biotechnologies

11.6.1 FUJIFILM Diosynth Biotechnologies Company Details

11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.6.3 FUJIFILM Diosynth Biotechnologies cGMP Process Development Introduction

11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in cGMP Process Development Business (2021–2026)

11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.7 Boehringer Ingelheim

11.7.1 Boehringer Ingelheim Company Details

11.7.2 Boehringer Ingelheim Business Overview

11.7.3 Boehringer Ingelheim cGMP Process Development Introduction

11.7.4 Boehringer Ingelheim Revenue in cGMP Process Development Business (2021–2026)

11.7.5 Boehringer Ingelheim Recent Development

11.8 Recipharm

11.8.1 Recipharm Company Details

11.8.2 Recipharm Business Overview

11.8.3 Recipharm cGMP Process Development Introduction

11.8.4 Recipharm Revenue in cGMP Process Development Business (2021–2026)

11.8.5 Recipharm Recent Development

11.9 Siegfried

11.9.1 Siegfried Company Details

11.9.2 Siegfried Business Overview

11.9.3 Siegfried cGMP Process Development Introduction

11.9.4 Siegfried Revenue in cGMP Process Development Business (2021–2026)

11.9.5 Siegfried Recent Development

11.10 Cambrex

11.10.1 Cambrex Company Details

11.10.2 Cambrex Business Overview

11.10.3 Cambrex cGMP Process Development Introduction

11.10.4 Cambrex Revenue in cGMP Process Development Business (2021–2026)

11.10.5 Cambrex Recent Development

11.11 WuXi STA

11.11.1 WuXi STA Company Details

11.11.2 WuXi STA Business Overview

11.11.3 WuXi STA cGMP Process Development Introduction

11.11.4 WuXi STA Revenue in cGMP Process Development Business (2021–2026)

11.11.5 WuXi STA Recent Development

11.12 Piramal Pharma Solutions

11.12.1 Piramal Pharma Solutions Company Details

11.12.2 Piramal Pharma Solutions Business Overview

11.12.3 Piramal Pharma Solutions cGMP Process Development Introduction

11.12.4 Piramal Pharma Solutions Revenue in cGMP Process Development Business (2021–2026)

11.12.5 Piramal Pharma Solutions Recent Development

11.13 Evonik Health Care

11.13.1 Evonik Health Care Company Details

11.13.2 Evonik Health Care Business Overview

11.13.3 Evonik Health Care cGMP Process Development Introduction

11.13.4 Evonik Health Care Revenue in cGMP Process Development Business (2021–2026)

11.13.5 Evonik Health Care Recent Development

11.14 AGC Biologics

11.14.1 AGC Biologics Company Details

11.14.2 AGC Biologics Business Overview

11.14.3 AGC Biologics cGMP Process Development Introduction

11.14.4 AGC Biologics Revenue in cGMP Process Development Business (2021–2026)

11.14.5 AGC Biologics Recent Development

11.15 Rentschler Biopharma

11.15.1 Rentschler Biopharma Company Details

11.15.2 Rentschler Biopharma Business Overview

11.15.3 Rentschler Biopharma cGMP Process Development Introduction

11.15.4 Rentschler Biopharma Revenue in cGMP Process Development Business (2021–2026)

11.15.5 Rentschler Biopharma Recent Development

11.16 KBI Biopharma

11.16.1 KBI Biopharma Company Details

11.16.2 KBI Biopharma Business Overview

11.16.3 KBI Biopharma cGMP Process Development Introduction

11.16.4 KBI Biopharma Revenue in cGMP Process Development Business (2021–2026)

11.16.5 KBI Biopharma Recent Development

11.17 Curia

11.17.1 Curia Company Details

11.17.2 Curia Business Overview

11.17.3 Curia cGMP Process Development Introduction

11.17.4 Curia Revenue in cGMP Process Development Business (2021–2026)

11.17.5 Curia Recent Development

11.18 Almac Pharma Services

11.18.1 Almac Pharma Services Company Details

11.18.2 Almac Pharma Services Business Overview

11.18.3 Almac Pharma Services cGMP Process Development Introduction

11.18.4 Almac Pharma Services Revenue in cGMP Process Development Business (2021–2026)

11.18.5 Almac Pharma Services Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

FUJIFILM Diosynth Biotechnologies

AGC Biologics

R&D Systems, Inc.

Lonza

Thermo Fisher Scientific

Piramal Pharma Solutions

Almac Pharma Services

List of Tables

Table 1. Global cGMP Process Development Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Microbial cGMP Manufacturing

Table 3. Key Players of Mammalian cGMP Manufacturing

Table 4. Key Players of Others

Table 5. Global cGMP Process Development Market Size Growth Rate by Service Phase (US$ Million): 2021 vs 2025 vs 2032

Table 6. Key Players of Preclinical Process Development

Table 7. Key Players of Clinical-Stage Process Development

Table 8. Key Players of Commercialization Process Development

Table 9. Global cGMP Process Development Market Size Growth Rate by Technology Platform (US$ Million): 2021 vs 2025 vs 2032

Table 10. Key Players of Chemical Synthesis Process Development Platform

Table 11. Key Players of Cell Culture Process Development Platform

Table 12. Key Players of Others

Table 13. Global cGMP Process Development Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 14. Global cGMP Process Development Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 15. Global cGMP Process Development Market Size by Region (US$ Million), 2021–2026

Table 16. Global cGMP Process Development Market Share by Region (2021–2026)

Table 17. Global cGMP Process Development Forecasted Market Size by Region (US$ Million), 2027–2032

Table 18. Global cGMP Process Development Market Share by Region (2027–2032)

Table 19. cGMP Process Development Market Trends

Table 20. cGMP Process Development Market Drivers

Table 21. cGMP Process Development Market Challenges

Table 22. cGMP Process Development Market Restraints

Table 23. Global cGMP Process Development Revenue by Players (US$ Million), 2021–2026

Table 24. Global cGMP Process Development Market Share by Players (2021–2026)

Table 25. Global Top cGMP Process Development Players by Tier (Tier 1, Tier 2, and Tier 3), based on cGMP Process Development Revenue, 2025

Table 26. Ranking of Global Top cGMP Process Development Companies by Revenue (US$ Million) in 2025

Table 27. Global 5 Largest Players Market Share by cGMP Process Development Revenue (CR5 and HHI), 2021–2026

Table 28. Global Key Players of cGMP Process Development, Headquarters and Area Served

Table 29. Global Key Players of cGMP Process Development, Products and Applications

Table 30. Global Key Players of cGMP Process Development, Date of General Availability (GA)

Table 31. Mergers and Acquisitions, Expansion Plans

Table 32. Global cGMP Process Development Market Size by Type (US$ Million), 2021–2026

Table 33. Global cGMP Process Development Revenue Market Share by Type (2021–2026)

Table 34. Global cGMP Process Development Forecasted Market Size by Type (US$ Million), 2027–2032

Table 35. Global cGMP Process Development Revenue Market Share by Type (2027–2032)

Table 36. Global cGMP Process Development Market Size by Application (US$ Million), 2021–2026

Table 37. Global cGMP Process Development Revenue Market Share by Application (2021–2026)

Table 38. Global cGMP Process Development Forecasted Market Size by Application (US$ Million), 2027–2032

Table 39. Global cGMP Process Development Revenue Market Share by Application (2027–2032)

Table 40. North America cGMP Process Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. North America cGMP Process Development Market Size by Country (US$ Million), 2021–2026

Table 42. North America cGMP Process Development Market Size by Country (US$ Million), 2027–2032

Table 43. Europe cGMP Process Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Europe cGMP Process Development Market Size by Country (US$ Million), 2021–2026

Table 45. Europe cGMP Process Development Market Size by Country (US$ Million), 2027–2032

Table 46. Asia-Pacific cGMP Process Development Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 47. Asia-Pacific cGMP Process Development Market Size by Region (US$ Million), 2021–2026

Table 48. Asia-Pacific cGMP Process Development Market Size by Region (US$ Million), 2027–2032

Table 49. Latin America cGMP Process Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 50. Latin America cGMP Process Development Market Size by Country (US$ Million), 2021–2026

Table 51. Latin America cGMP Process Development Market Size by Country (US$ Million), 2027–2032

Table 52. Middle East & Africa cGMP Process Development Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 53. Middle East & Africa cGMP Process Development Market Size by Country (US$ Million), 2021–2026

Table 54. Middle East & Africa cGMP Process Development Market Size by Country (US$ Million), 2027–2032

Table 55. Lonza Company Details

Table 56. Lonza Business Overview

Table 57. Lonza cGMP Process Development Product

Table 58. Lonza Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 59. Lonza Recent Development

Table 60. Thermo Fisher Scientific Company Details

Table 61. Thermo Fisher Scientific Business Overview

Table 62. Thermo Fisher Scientific cGMP Process Development Product

Table 63. Thermo Fisher Scientific Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 64. Thermo Fisher Scientific Recent Development

Table 65. Catalent Company Details

Table 66. Catalent Business Overview

Table 67. Catalent cGMP Process Development Product

Table 68. Catalent Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 69. Catalent Recent Development

Table 70. Samsung Biologics Company Details

Table 71. Samsung Biologics Business Overview

Table 72. Samsung Biologics cGMP Process Development Product

Table 73. Samsung Biologics Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 74. Samsung Biologics Recent Development

Table 75. WuXi Biologics Company Details

Table 76. WuXi Biologics Business Overview

Table 77. WuXi Biologics cGMP Process Development Product

Table 78. WuXi Biologics Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 79. WuXi Biologics Recent Development

Table 80. FUJIFILM Diosynth Biotechnologies Company Details

Table 81. FUJIFILM Diosynth Biotechnologies Business Overview

Table 82. FUJIFILM Diosynth Biotechnologies cGMP Process Development Product

Table 83. FUJIFILM Diosynth Biotechnologies Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 84. FUJIFILM Diosynth Biotechnologies Recent Development

Table 85. Boehringer Ingelheim Company Details

Table 86. Boehringer Ingelheim Business Overview

Table 87. Boehringer Ingelheim cGMP Process Development Product

Table 88. Boehringer Ingelheim Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 89. Boehringer Ingelheim Recent Development

Table 90. Recipharm Company Details

Table 91. Recipharm Business Overview

Table 92. Recipharm cGMP Process Development Product

Table 93. Recipharm Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 94. Recipharm Recent Development

Table 95. Siegfried Company Details

Table 96. Siegfried Business Overview

Table 97. Siegfried cGMP Process Development Product

Table 98. Siegfried Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 99. Siegfried Recent Development

Table 100. Cambrex Company Details

Table 101. Cambrex Business Overview

Table 102. Cambrex cGMP Process Development Product

Table 103. Cambrex Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 104. Cambrex Recent Development

Table 105. WuXi STA Company Details

Table 106. WuXi STA Business Overview

Table 107. WuXi STA cGMP Process Development Product

Table 108. WuXi STA Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 109. WuXi STA Recent Development

Table 110. Piramal Pharma Solutions Company Details

Table 111. Piramal Pharma Solutions Business Overview

Table 112. Piramal Pharma Solutions cGMP Process Development Product

Table 113. Piramal Pharma Solutions Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 114. Piramal Pharma Solutions Recent Development

Table 115. Evonik Health Care Company Details

Table 116. Evonik Health Care Business Overview

Table 117. Evonik Health Care cGMP Process Development Product

Table 118. Evonik Health Care Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 119. Evonik Health Care Recent Development

Table 120. AGC Biologics Company Details

Table 121. AGC Biologics Business Overview

Table 122. AGC Biologics cGMP Process Development Product

Table 123. AGC Biologics Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 124. AGC Biologics Recent Development

Table 125. Rentschler Biopharma Company Details

Table 126. Rentschler Biopharma Business Overview

Table 127. Rentschler Biopharma cGMP Process Development Product

Table 128. Rentschler Biopharma Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 129. Rentschler Biopharma Recent Development

Table 130. KBI Biopharma Company Details

Table 131. KBI Biopharma Business Overview

Table 132. KBI Biopharma cGMP Process Development Product

Table 133. KBI Biopharma Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 134. KBI Biopharma Recent Development

Table 135. Curia Company Details

Table 136. Curia Business Overview

Table 137. Curia cGMP Process Development Product

Table 138. Curia Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 139. Curia Recent Development

Table 140. Almac Pharma Services Company Details

Table 141. Almac Pharma Services Business Overview

Table 142. Almac Pharma Services cGMP Process Development Product

Table 143. Almac Pharma Services Revenue in cGMP Process Development Business (US$ Million), 2021–2026

Table 144. Almac Pharma Services Recent Development

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

Table 148. Authors List of This Report

List of Figures

Figure 1. cGMP Process Development Picture

Figure 2. Global cGMP Process Development Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global cGMP Process Development Market Share by Type: 2025 vs 2032

Figure 4. Microbial cGMP Manufacturing Features

Figure 5. Mammalian cGMP Manufacturing Features

Figure 6. Others Features

Figure 7. Global cGMP Process Development Market Size Comparison by Service Phase (US$ Million), 2021–2032

Figure 8. Preclinical Process Development Features

Figure 9. Clinical-Stage Process Development Features

Figure 10. Commercialization Process Development Features

Figure 11. Global cGMP Process Development Market Size Comparison by Technology Platform (US$ Million), 2021–2032

Figure 12. Chemical Synthesis Process Development Platform Features

Figure 13. Cell Culture Process Development Platform Features

Figure 14. Others Features

Figure 15. Global cGMP Process Development Market Size by Application (US$ Million), 2021–2032

Figure 16. Global cGMP Process Development Market Share by Application: 2025 vs 2032

Figure 17. Pharmaceutical Case Studies

Figure 18. Biotechnology Case Studies

Figure 19. Others Case Studies

Figure 20. cGMP Process Development Report Years Considered

Figure 21. Global cGMP Process Development Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 22. Global cGMP Process Development Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global cGMP Process Development Market Share by Region: 2025 vs 2032

Figure 24. Global cGMP Process Development Market Share by Players in 2025

Figure 25. Global cGMP Process Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 26. The Top 10 and 5 Players Market Share by cGMP Process Development Revenue in 2025

Figure 27. North America cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. North America cGMP Process Development Market Share by Country (2021–2032)

Figure 29. United States cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Canada cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Europe cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Europe cGMP Process Development Market Share by Country (2021–2032)

Figure 33. Germany cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. France cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. U.K. cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Italy cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Russia cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Ireland cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Asia-Pacific cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Asia-Pacific cGMP Process Development Market Share by Region (2021–2032)

Figure 41. China cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Japan cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. South Korea cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Southeast Asia cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. India cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Australia & New Zealand cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Latin America cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Latin America cGMP Process Development Market Share by Country (2021–2032)

Figure 49. Mexico cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Brazil cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Middle East & Africa cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Middle East & Africa cGMP Process Development Market Share by Country (2021–2032)

Figure 53. Israel cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Saudi Arabia cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. UAE cGMP Process Development Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Lonza Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 57. Thermo Fisher Scientific Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 58. Catalent Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 59. Samsung Biologics Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 60. WuXi Biologics Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 61. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 62. Boehringer Ingelheim Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 63. Recipharm Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 64. Siegfried Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 65. Cambrex Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 66. WuXi STA Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 67. Piramal Pharma Solutions Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 68. Evonik Health Care Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 69. AGC Biologics Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 70. Rentschler Biopharma Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 71. KBI Biopharma Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 72. Curia Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 73. Almac Pharma Services Revenue Growth Rate in cGMP Process Development Business (2021–2026)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Process Development Service Market Research Report 2025

Global Cell Culture Process Development Market Research Report 2024

Global Fermentation Process Development Market Research Report 2025

Global API Process Development Market Research Report 2025

cGMP Sterile Filling Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Process Liquid Market Research Report 2024

Global API Process Development and Manufacturing Market Research Report 2025

Global Process Engineering Development Service Market Research Report 2025

Global Process Catalysts Market Research Report 2025

Global Guanosine Monophosphate Market Research Report 2024

Global Process Photometers Market Research Report 2025

Global CMP Filter Market Research Report 2025

Global Process Mixed Mode Chromatography Market Research Report 2025

Global cGMP Stock Solution Market Research Report 2024

Global Non GMP Development Market Research Report 2024

Global Process Calibration Instruments Market Research Report 2025

Global Process Pressure Gauge Market Research Report 2025

Global Project Development and Management Market Research Report 2025

Global Process Simulation and Optimization Software Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions